Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Isoniazid/pyrazinamide

Isoniazid/pyrazinamide Reactions 1704, p212 - 2 Jun 2018 Hepatotoxicity and widespread arthralgias: case report A 61-year-old woman developed hepatotoxicity during treatment with isoniazid and widespread arthralgias during treatment with pyrazinamide for cutaneous infection of Mycobacterium tuberculosis [routes not stated]. The woman presented with a solitary large black nodular lesion overlying her right proximal interphalangeal joint on her index finger since last one year. Considering a possibility of mycobacterial infection, she was empirically treated with anti- mycobacterial therapy, which consisted of isoniazid 300 mg/day, rifampicin, ethambutol, pyrazinamide 1.5 g/day and pyridoxine. It was later confirmed that she had Mycobacterium tuberculosis infection. A clinical response was obtained, however, she subsequently developed isoniazid- induced hepatotoxicity and widespread arthralgias [durations of treatments to reactions onsets not stated]. It was suspected that the arthralgia was secondary to pyrazinamide. The woman’s isoniazid and pyrazinamide therapies were consequently stopped, and the anti-tuberculous therapy was switched to moxifloxacin and clarithromycin [outcomes not stated]. Author comment: "Despite a clinical response, isoniazid was ceased secondary to isoniazid-induced hepatotoxicity, pyrazinamide was ceased due to widespread arthralgias." Laidler N. Cutaneous infection with paucibacillary mycobacterium tuberculosis treated successfully with a modified antituberculous drug regimen. Australasian Journal of Dermatology 59 (Suppl. 1): 80 (plus http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Isoniazid/pyrazinamide

Reactions Weekly , Volume 1704 (1) – Jun 2, 2018
Download PDF
1 page

Isoniazid/pyrazinamide

Abstract

Reactions 1704, p212 - 2 Jun 2018 Hepatotoxicity and widespread arthralgias: case report A 61-year-old woman developed hepatotoxicity during treatment with isoniazid and widespread arthralgias during treatment with pyrazinamide for cutaneous infection of Mycobacterium tuberculosis [routes not stated]. The woman presented with a solitary large black nodular lesion overlying her right proximal interphalangeal joint on her index finger since last one year. Considering a possibility of...
Loading next page...
 
/lp/springer_journal/isoniazid-pyrazinamide-LN7DFalz4p

References (1)

Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
DOI
10.1007/s40278-018-46855-3
Publisher site
See Article on Publisher Site

Abstract

Reactions 1704, p212 - 2 Jun 2018 Hepatotoxicity and widespread arthralgias: case report A 61-year-old woman developed hepatotoxicity during treatment with isoniazid and widespread arthralgias during treatment with pyrazinamide for cutaneous infection of Mycobacterium tuberculosis [routes not stated]. The woman presented with a solitary large black nodular lesion overlying her right proximal interphalangeal joint on her index finger since last one year. Considering a possibility of mycobacterial infection, she was empirically treated with anti- mycobacterial therapy, which consisted of isoniazid 300 mg/day, rifampicin, ethambutol, pyrazinamide 1.5 g/day and pyridoxine. It was later confirmed that she had Mycobacterium tuberculosis infection. A clinical response was obtained, however, she subsequently developed isoniazid- induced hepatotoxicity and widespread arthralgias [durations of treatments to reactions onsets not stated]. It was suspected that the arthralgia was secondary to pyrazinamide. The woman’s isoniazid and pyrazinamide therapies were consequently stopped, and the anti-tuberculous therapy was switched to moxifloxacin and clarithromycin [outcomes not stated]. Author comment: "Despite a clinical response, isoniazid was ceased secondary to isoniazid-induced hepatotoxicity, pyrazinamide was ceased due to widespread arthralgias." Laidler N. Cutaneous infection with paucibacillary mycobacterium tuberculosis treated successfully with a modified antituberculous drug regimen. Australasian Journal of Dermatology 59 (Suppl. 1): 80 (plus

Journal

Reactions Weekly – Springer Journals

Published: Jun 2, 2018

There are no references for this article.